HDAC9 and chondrosarcoma: However, HDAC inhibition could not sensitize chondrosarcoma cells to four different types of chemotherapy (i.e., aclarubicin, cisplatin, doxorubicin, and temozolomide), although this has been extensively described in other tumor types [22].